Tyra Biosciences, Inc.
US ˙ NasdaqGS ˙ US90240B1061

SecurityTYRA / Tyra Biosciences, Inc.
InstitutionONEQ - Fidelity Nasdaq Composite Index Tracking Stock
Latest Disclosed Ownership21,807 shares
Latest Disclosed Value $ 198,443
ONEQ - Fidelity Nasdaq Composite Index Tracking Stock reports 0.46% increase in ownership of TYRA / Tyra Biosciences, Inc.

On July 24, 2025 - ONEQ - Fidelity Nasdaq Composite Index Tracking Stock filed a NPORT-P form disclosing ownership of 21,807 shares of Tyra Biosciences, Inc. (US:TYRA) valued at $198,444 USD as of May 31, 2025. The entity filed a previous NPORT-P on April 25, 2025 disclosing 21,707 shares of Tyra Biosciences, Inc.. This represents a change in shares of 0.46% during the quarter. The current value of the position is $580,938 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-07-24 2025-05-31 NP TYRA BIOSCIENCES EC US90240B1061 21,807 100 0.46 198 -22.05 0.0026
2025-04-25 2025-02-28 NP TYRA BIOSCIENCES EC US90240B1061 21,707 540 2.55 254 -23.26 0.0034
2025-01-27 2024-11-30 NP TYRA BIOSCIENCES EC US90240B1061 21,167 140 0.67 332 -30.75 0.0045
2024-10-29 2024-08-31 NP TYRA BIOSCIENCES EC US90240B1061 21,027 190 0.91 479 41.84 0.0071
2024-07-26 2024-05-31 NP TYRA BIOSCIENCES EC US90240B1061 20,837 250 1.21 338 -18.00 0.0054
2024-04-24 2024-02-29 NP TYRA BIOSCIENCES EC US90240B1061 20,587 5,360 35.20 412 130.90 0.0069
2024-01-24 2023-11-30 NP TYRA BIOSCIENCES EC US90240B1061 15,227 3,331 28.00 178 -1.66 0.0034
2023-10-27 2023-08-31 NP TYRA BIOSCIENCES EC US90240B1061 11,896 7,025 144.22 181 158.57 0.0035
2023-07-26 2023-05-31 NP TYRA BIOSCIENCES EC US90240B1061 4,871 4,871 70 0.0015
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.